Loading…

Medical Research Finder

meRfi® Microbiome - The Digital Gut Microbiome Reference (incl. AI Chat)
Prebiotics, Probiotics, FMT / Manipulators of the Intestinal Microbiota

AuthorsReferences (Sources)

Pembrolizumab & Primary mediastinal B-cell lymphoma (PMBCL)

Welcome to meRfi Microbiome!

Please register to continue your trial period!

meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.

Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.

Start your free trial and transform your understanding of the gut microbiota today!

Pembrolizumab showed tolerable safety profile and efficacy data in patients with Primary mediastinal B-cell lymphoma (PMBCL) who have relapsed after, or are ineligible for ASCT (autologous stem cell transplantation)

References:
Camus et al. 2021 Expert Review of Anticancer Therapy 21(9): 941-956

…

Pembrolizumab in Relapsed or Refractory Primary Mediastinal Large B-Cell Lymphoma
Armand et al. 2019
Pembrolizumab in the treatment of refractory primary mediastinal large B-cell lymphoma: safety and efficacy
Camus et al. 2021 Expert Review of Anticancer Therapy 21(9): 941-956

7/1/2026